STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention. Vergallo R, Patrono C. Eur Heart J 2024 Nov 19:ehae773. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vergallo R, Patrono C. STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention. Eur Heart J 2024 Nov 19:ehae773. doi: 10.1093.
PMID: 39560672